Zevra Therapeutics, Inc. (ZVRA)
10.12
+0.06
(+0.65%)
USD |
NASDAQ |
Oct 28, 10:05
Zevra Therapeutics Price : 10.12 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 9.53 | 10.27 | 9.49 | 10.06 | 1.090M |
| Oct 26, 2026 | 9.84 | 9.89 | 9.46 | 9.53 | 722197.0 |
| Oct 23, 2026 | 10.25 | 10.25 | 9.76 | 9.81 | 978005.0 |
| Oct 22, 2026 | 10.36 | 10.61 | 10.24 | 10.33 | 537297.0 |
| Oct 21, 2026 | 10.48 | 10.50 | 10.32 | 10.36 | 500585.0 |
| Oct 20, 2026 | 10.31 | 10.56 | 10.22 | 10.47 | 432255.0 |
| Oct 19, 2026 | 9.94 | 10.20 | 9.84 | 10.16 | 720244.0 |
| Oct 16, 2026 | 10.29 | 10.29 | 9.885 | 9.94 | 593885.0 |
| Oct 15, 2026 | 10.40 | 10.60 | 10.22 | 10.27 | 462450.0 |
| Oct 14, 2026 | 10.10 | 10.60 | 10.08 | 10.23 | 752673.0 |
| Oct 13, 2026 | 11.33 | 11.33 | 10.24 | 10.39 | 1.091M |
| Oct 12, 2026 | 11.39 | 11.39 | 11.07 | 11.32 | 509037.0 |
| Oct 09, 2026 | 10.95 | 11.46 | 10.95 | 11.39 | 730743.0 |
| Oct 08, 2026 | 11.05 | 11.09 | 10.87 | 11.00 | 487124.0 |
| Oct 07, 2026 | 10.68 | 11.38 | 10.57 | 11.08 | 936491.0 |
| Oct 06, 2026 | 10.76 | 10.88 | 10.44 | 10.73 | 614595.0 |
| Oct 05, 2026 | 10.01 | 10.80 | 10.00 | 10.70 | 1.978M |
| Oct 02, 2026 | 10.24 | 10.24 | 9.845 | 9.99 | 951870.0 |
| Oct 01, 2026 | 10.91 | 10.96 | 10.15 | 10.18 | 1.301M |
| Sep 30, 2026 | 11.37 | 11.38 | 10.94 | 10.97 | 1.818M |
| Sep 29, 2026 | 11.28 | 11.50 | 11.20 | 11.34 | 1.347M |
| Sep 28, 2026 | 11.01 | 11.36 | 10.89 | 11.30 | 751309.0 |
| Sep 25, 2026 | 11.29 | 11.30 | 11.01 | 11.04 | 678558.0 |
| Sep 24, 2026 | 11.28 | 11.32 | 11.06 | 11.26 | 593987.0 |
| Sep 23, 2026 | 11.58 | 11.58 | 11.15 | 11.32 | 735894.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Innoviva, Inc. | 20.94 |
| Xeris Biopharma Holdings, Inc. | 10.60 |
| ANI Pharmaceuticals, Inc. | 71.02 |
| Corcept Therapeutics, Inc. | 87.08 |
| Veru, Inc. | 2.255 |
Price Related Metrics
| PE Ratio | 10.92 |
| PS Ratio | 4.418 |
| Price to Book Value | 2.759 |
| Price to Free Cash Flow | 18.43 |
| Earnings Yield | 9.16% |
| Market Cap | 600.54M |
| Operating PE Ratio | 15.39 |
| Normalized PE Ratio | 8.921 |